- Press Release -

Rockville, Md. The global radiotherapy devices market is set to top US$ 10 Bn by 2031, roughly doubling over the decade at a 7% CAGR, according to Fact.MR. These devices deliver precise, high-energy radiation to targeted areas of the body, and as radiation therapy stays central to treating a wide range of cancers, demand for the equipment keeps climbing.

Linear accelerators dominate the product mix and Europe leads by region. Both clinicians and patients are drawn to radiotherapy for shortening hospital stays and controlling tumour growth, which continues to widen adoption.

Products, Procedures and Regions

Linear accelerator devices are the clear leaders, heading toward about US$ 4.5 Bn by 2031, while internal beam radiotherapy systems reach US$ 1.2 Bn. By procedure, systemic radiotherapy grows at above 5% over the period. Europe holds more than half of the global market, and South Korea grows at a 4% CAGR through the forecast.

Innovation Reshapes Cancer Care

Higher device efficacy, a steady stream of novel therapies, and government initiatives for cancer care are the main forces lifting demand. Technology partnerships are pushing the field further. In October 2020, Mayo Clinic and Google Health announced work on artificial intelligence to improve radiation therapy planning, developing an algorithm to separate tumours from healthy tissue and organs.

Competitive Landscape

Opportunity for leading companies rests on greater government support for organised cancer research and the chance to upgrade existing equipment as technology advances. Keeping pace with the latest developments is central to how radiotherapy device makers set strategy.

Reading the Market for Decisions

For device makers, growth favours linear accelerator platforms and AI-enabled planning. Investors get a market with a firm clinical tailwind and a doubling trajectory. Procurement and hospital teams can plan around linear accelerators leading supply and Europe carrying the largest share through 2031.

About the Report

Fact.MR's study covers the global radiotherapy devices market with historical data for 2016 to 2020 and forecasts for 2021 to 2031, segmented by product, procedure, application and end user across seven regions. It sizes each segment, maps the competitive field, and weighs the clinical and technology forces shaping demand. Further detail is available in the radiotherapy devices market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.